×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Ch... [19]
THE STATE KEY L... [14]
Faculty of Healt... [6]
Faculty of Law [1]
Faculty of Scien... [1]
Authors
HU YUANJIA [21]
YU HUA [7]
WANG YITAO [2]
XIANG YUTAO [1]
YANG ZHIXIN [1]
BIAN YING [1]
More...
Document Type
Journal article [21]
Date Issued
2024 [2]
2023 [2]
2022 [6]
2021 [5]
2020 [1]
2018 [2]
More...
Language
英語English [20]
中文Chinese [1]
Source Publication
ACTA PHARMACOLOG... [1]
AMERICAN JOURNAL... [1]
Analytical and B... [1]
BioMed Research ... [1]
Cancer [1]
Carbohydrate Pol... [1]
More...
Indexed By
SCIE [13]
CSCD [1]
ESCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 21
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Issue Date Ascending
Issue Date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Exploring the mechanisms of Yuanhu Zhitong oral liquid for primary dysmenorrhea through network pharmacology, molecular docking, and molecular dynamics simulation
Journal article
Zhang, Cheng Rui, Zhang, Dai Yan, Gao, Jin, Cao, Zhi Ming, Hu, Yuan Jia. Exploring the mechanisms of Yuanhu Zhitong oral liquid for primary dysmenorrhea through network pharmacology, molecular docking, and molecular dynamics simulation[J]. Reproductive and Developmental Medicine, 2024, 8(3), 138-150.
Authors:
Zhang, Cheng Rui
;
Zhang, Dai Yan
;
Gao, Jin
;
Cao, Zhi Ming
;
Hu, Yuan Jia
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
0.7
/
0.6
|
Submit date:2024/10/10
Molecular Docking
Network Pharmacology
Primary Dysmenorrhea
Yuanhu Zhitong Oral Liquid
Characteristics of clinical trials of new oncology drugs approved in China
Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:
Yang, Jing
;
Yang, Ji
;
Hu, Yuan Jia
Favorite
|
TC[WOS]:
1
TC[Scopus]:
2
IF:
6.1
/
6.7
|
Submit date:2024/05/16
Clinical Evidence
Drug Lag
Novel Anticancer Drugs
Pivotal Clinical Trials
Programmed Death-1 (Pd-1) Inhibitors
Programmed Death-ligand 1 (Pd-l1) Inhibitors
Leocarpinolide B Attenuates Collagen Type II-Induced Arthritis by Inhibiting DNA Binding Activity of NF-κB
Journal article
Linghu, Ke Gang, Zhao, Guan Ding, Zhang, Dai Yan, Xiong, Shi Hang, Wu, Guo Ping, Shen, Li Yu, Cui, Wen Qing, Zhang, Tian, Hu, Yuan Jia, Guo, Bing, Shen, Xiang Chun, Yu, Hua. Leocarpinolide B Attenuates Collagen Type II-Induced Arthritis by Inhibiting DNA Binding Activity of NF-κB[J]. Molecules (Basel, Switzerland), 2023, 28(10), 4241.
Authors:
Linghu, Ke Gang
;
Zhao, Guan Ding
;
Zhang, Dai Yan
;
Xiong, Shi Hang
;
Wu, Guo Ping
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
3
IF:
4.2
/
4.6
|
Submit date:2023/06/05
Leocarpinolide b
Nf-κb P65
Rheumatoid Arthritis
Sesquiterpene Lactone
Synovitis
Mechanisms of Ganweikang Tablets against Chronic Hepatitis B: A Comprehensive Study of Network Analysis, Molecular Docking, and Chemical Profiling
Journal article
Xu,Jia Qi, Su,Shi Bing, Chen,C. Y., Gao,J., Cao,Z. M., Guan,J. L., Xiao,Lin Xuan, Zhao,Ming Ming, Yu,Hua, Hu,Yuan Jia. Mechanisms of Ganweikang Tablets against Chronic Hepatitis B: A Comprehensive Study of Network Analysis, Molecular Docking, and Chemical Profiling[J]. BioMed Research International, 2023, 2023.
Authors:
Xu,Jia Qi
;
Su,Shi Bing
;
Chen,C. Y.
;
Gao,J.
;
Cao,Z. M.
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
3
IF:
2.6
/
3.1
|
Submit date:2023/08/03
Delivery of therapeutic small interfering RNA: The current patent-based landscape
Journal article
Chen, Yu, Xiong, Shi Hang, Li, Fei, Kong, Xiang Jun, Ouyang, De Fang, Zheng, Ying, Yu, Hua, Hu, Yuan Jia. Delivery of therapeutic small interfering RNA: The current patent-based landscape[J]. Molecular Therapy - Nucleic Acids, 2022, 29, 150-161.
Authors:
Chen, Yu
;
Xiong, Shi Hang
;
Li, Fei
;
Kong, Xiang Jun
;
Ouyang, De Fang
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
6
IF:
6.5
/
6.7
|
Submit date:2023/06/29
Delivery Technology
Patent Landscape
Therapeutic Sirna
Preparation of Fe3O4@SW-MIL-101-NH2 for selective pre-concentration of chlorogenic acid metabolites in rat plasma, urine, and feces samples
Journal article
Yin, Shi Jun, Zhou, Xi, Peng, Li Jing, Li, Fang, Zheng, Guo Can, Yang, Feng Qing, Hu, Yuan Jia. Preparation of Fe3O4@SW-MIL-101-NH2 for selective pre-concentration of chlorogenic acid metabolites in rat plasma, urine, and feces samples[J]. Journal of Pharmaceutical Analysis, 2022, 12(4), 617-626.
Authors:
Yin, Shi Jun
;
Zhou, Xi
;
Peng, Li Jing
;
Li, Fang
;
Zheng, Guo Can
; et al.
Favorite
|
TC[WOS]:
17
TC[Scopus]:
17
IF:
6.1
/
6.8
|
Submit date:2022/08/05
Chlorogenic Acid
Magnetic Solid-phase Extraction
Metabolic Pathway
Metal-organic Framework
Sandwich Structure
A network pharmacology-based study on the quality control markers of antithrombotic herbs: Using Salvia miltiorrhiza - Ligusticum chuanxiong as an example
Journal article
Zhang, Dai Yan, Peng, Ruo Qian, Wang, Xu, Zuo, Hua Li, Lyu, Li Yang, Yang, Feng Qing, Hu, Yuan Jia. A network pharmacology-based study on the quality control markers of antithrombotic herbs: Using Salvia miltiorrhiza - Ligusticum chuanxiong as an example[J]. Journal of Ethnopharmacology, 2022, 292(115197).
Authors:
Zhang, Dai Yan
;
Peng, Ruo Qian
;
Wang, Xu
;
Zuo, Hua Li
;
Lyu, Li Yang
; et al.
Favorite
|
TC[WOS]:
16
TC[Scopus]:
18
IF:
4.8
/
4.8
|
Submit date:2022/05/13
Salvia Miltiorrhiza
Ligusticum Chuanxiong
Network Pharmacology
Bilayer Network
Quality Control Markers
The Changing Global Landscape in the Development of Artemisinin-Based Treatments: A Clinical Trial Perspective
Journal article
Kong, Xiang Jun, Liu, Kun Meng, Zuo, Hua Li, Huang, Hsien Da, Hu, Yuan Jia. The Changing Global Landscape in the Development of Artemisinin-Based Treatments: A Clinical Trial Perspective[J]. AMERICAN JOURNAL OF CHINESE MEDICINE, 2022, 50(3), 733-748.
Authors:
Kong, Xiang Jun
;
Liu, Kun Meng
;
Zuo, Hua Li
;
Huang, Hsien Da
;
Hu, Yuan Jia
Favorite
|
TC[WOS]:
5
TC[Scopus]:
3
IF:
4.8
/
5.0
|
Submit date:2022/05/17
Artemisinin
Artemisinin-based Combination Therapy
Clinical Trial
Malaria
Non-malarial Indication
Review
Traditional Chinese medicine network pharmacology: development in new era under guidance of network pharmacology evaluation method guidance 中医药网络药理学: 《指南》引领下的新时代发展
Journal article
Wang, Zi Yi, Wang, Xin, Zhang, Dai Yan, Hu, Yuan Jia, Li, Shao. Traditional Chinese medicine network pharmacology: development in new era under guidance of network pharmacology evaluation method guidance 中医药网络药理学: 《指南》引领下的新时代发展[J]. Zhongguo Zhongyao Zazhi, 2022, 47(1), 7-17.
Authors:
Wang, Zi Yi
;
Wang, Xin
;
Zhang, Dai Yan
;
Hu, Yuan Jia
;
Li, Shao
Favorite
|
TC[Scopus]:
57
|
Submit date:2022/02/21
Network Pharmacology
Network Pharmacology Evaluation Method Guidance
Network Target
Traditional Chinese Medicine
COVID-19 prevention and control strategies: learning from the Macau model
Journal article
Zhao, Yan Jie, Xu, Jia Qi, Bai, Wei, Sun, He Li, Shui, Bing, Yang, Zhi Xin, Huang, Jingbo, Smith, Robert D., Hu, Yuan Jia, Xiang, Yu Tao. COVID-19 prevention and control strategies: learning from the Macau model[J]. International Journal of Biological Sciences, 2022, 18(14), 5317-5328.
Authors:
Zhao, Yan Jie
;
Xu, Jia Qi
;
Bai, Wei
;
Sun, He Li
;
Shui, Bing
; et al.
Favorite
|
TC[WOS]:
7
TC[Scopus]:
6
IF:
8.2
/
8.3
|
Submit date:2023/02/15
Covid-19
Macau
Strategy